Merck signs definitive agreement to acquire Mirus Bio
Merck has signed a definitive agreement to acquire Mirus Bio for $600 million. Mirus Bio, part of Gamma Biosciences, is a life science company based in Madison, Wisconsin, USA that specializes in the development and commercialization of transfection …